Zifeng Wang

2.6k total citations
80 papers, 1.6k citations indexed

About

Zifeng Wang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Zifeng Wang has authored 80 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 17 papers in Cancer Research and 15 papers in Oncology. Recurrent topics in Zifeng Wang's work include Cancer-related molecular mechanisms research (10 papers), MicroRNA in disease regulation (7 papers) and Epigenetics and DNA Methylation (7 papers). Zifeng Wang is often cited by papers focused on Cancer-related molecular mechanisms research (10 papers), MicroRNA in disease regulation (7 papers) and Epigenetics and DNA Methylation (7 papers). Zifeng Wang collaborates with scholars based in China, United States and Hong Kong. Zifeng Wang's co-authors include Zhanfang Ma, Na Liu, Gang Lü, Dan Xie, Sheng Lin, Kiyohiro Houkin, Masahito Kawabori, Hong Yao, Marie C. Lin and Quentin Liu and has published in prestigious journals such as Science, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Zifeng Wang

77 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zifeng Wang China 24 1.0k 486 262 199 174 80 1.6k
Xiangyu Gao China 21 685 0.7× 397 0.8× 229 0.9× 188 0.9× 208 1.2× 134 1.5k
Wei Mu China 22 1.0k 1.0× 501 1.0× 175 0.7× 210 1.1× 99 0.6× 47 1.6k
Zongyou Chen China 27 991 1.0× 684 1.4× 438 1.7× 384 1.9× 214 1.2× 97 2.1k
Yunhao Chen China 19 1.4k 1.3× 869 1.8× 283 1.1× 132 0.7× 208 1.2× 38 2.0k
Ké Li China 22 785 0.8× 251 0.5× 357 1.4× 228 1.1× 125 0.7× 96 1.5k
Teodora Nikolova Germany 28 1.4k 1.3× 496 1.0× 439 1.7× 88 0.4× 208 1.2× 58 2.2k
Liqun Xia China 23 1.3k 1.2× 742 1.5× 232 0.9× 114 0.6× 195 1.1× 66 1.8k
Tingting Zeng China 27 1.2k 1.2× 716 1.5× 486 1.9× 254 1.3× 226 1.3× 96 2.0k

Countries citing papers authored by Zifeng Wang

Since Specialization
Citations

This map shows the geographic impact of Zifeng Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zifeng Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zifeng Wang more than expected).

Fields of papers citing papers by Zifeng Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zifeng Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zifeng Wang. The network helps show where Zifeng Wang may publish in the future.

Co-authorship network of co-authors of Zifeng Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Zifeng Wang. A scholar is included among the top collaborators of Zifeng Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zifeng Wang. Zifeng Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tang, Hao, Zifeng Wang, Yonghui Zhang, et al.. (2025). A Sustainable Computing-Based Multi-Objective Feeding Scheduling Model for Low-Carbon Factory Aquaculture Using Enhanced NSGA-II in Agricultural Consumer Electronics. IEEE Transactions on Consumer Electronics. 71(2). 6989–7001. 2 indexed citations
2.
Bai, Shanshan, Tiantian Huang, Tao Lu, et al.. (2025). Therapeutic potential of luteolin in central precocious puberty: insights from a danazol-induced rat model. Frontiers in Endocrinology. 16. 1666932–1666932.
3.
Wang, Zifeng, et al.. (2025). Accelerating clinical evidence synthesis with large language models. npj Digital Medicine. 8(1). 509–509. 5 indexed citations
4.
Wang, Zifeng, Nana Chen, Xin‐Hao Li, et al.. (2025). Chromatin looping-based CRISPR screen identifies TLK2 as chromatin loop formation regulator in cancer stemness plasticity. Nature Communications. 16(1). 9288–9288.
5.
Yao, Yu, Yutong Han, Zifeng Wang, et al.. (2024). Transient MBene surpassing MXene for high-selectivity NH3 sensing in meat spoilage detection. Chemical Engineering Journal. 503. 158516–158516. 9 indexed citations
6.
Kuang, Shuhong, Yong Zhang, Zongshan Shen, et al.. (2024). Multiomics profiling reveals VDR as a central regulator of mesenchymal stem cell senescence with a known association with osteoporosis after high-fat diet exposure. International Journal of Oral Science. 16(1). 41–41. 12 indexed citations
7.
Wang, Manman, Xing Zhang, Zifeng Wang, et al.. (2024). Study on the crystal structure and properties of a new crystal form of 3-nitro-1,2,4-triazole-5-one (NTO). CrystEngComm. 26(26). 3501–3508. 2 indexed citations
8.
Liu, Fang, Nana Chen, Xin‐Hao Li, et al.. (2024). AURKA emerges as a vulnerable target for KEAP1-deficient non-small cell lung cancer by activation of asparagine synthesis. Cell Death and Disease. 15(3). 233–233. 6 indexed citations
9.
Wang, Zifeng, Scott L. Townley, Mu‐Qing Li, et al.. (2024). FOXA2 rewires AP-1 for transcriptional reprogramming and lineage plasticity in prostate cancer. Nature Communications. 15(1). 4914–4914. 13 indexed citations
10.
Zhu, Qian, et al.. (2024). TOX2 nuclear-cytosol translocation is linked to leukemogenesis of acute T-cell leukemia by repressing TIM3 transcription. Cell Death and Differentiation. 31(11). 1506–1518. 4 indexed citations
11.
Wang, Zifeng, et al.. (2023). Smoking, alcohol consumption and risk of Dupuytren’s disease: a Mendelian randomization study. BMC Medical Genomics. 16(1). 212–212. 5 indexed citations
12.
Yue, Caifeng, Chang Wang, Jiewei Chen, et al.. (2023). TRIM29 acts as a potential senescence suppressor with epigenetic activation in nasopharyngeal carcinoma. Cancer Science. 114(8). 3176–3189. 6 indexed citations
13.
Wang, Zifeng, Chan Zhang, Xiaoning Li, et al.. (2023). Targeting B4GALT7 suppresses the proliferation, migration and invasion of hepatocellular carcinoma through the Cdc2/CyclinB1 and miR-338-3p/MMP2 pathway. PeerJ. 11. e16450–e16450. 4 indexed citations
14.
Wang, Zifeng & Jimeng Sun. (2022). Trial2Vec: Zero-Shot Clinical Trial Document Similarity Search using Self-Supervision. 6377–6390. 11 indexed citations
15.
Han, Wanting, Dong Han, Zifeng Wang, et al.. (2022). Exploiting the tumor-suppressive activity of the androgen receptor by CDK4/6 inhibition in castration-resistant prostate cancer. Molecular Therapy. 30(4). 1628–1644. 25 indexed citations
16.
Han, Wanting, Dong Han, Zifeng Wang, et al.. (2022). RB1 loss in castration-resistant prostate cancer confers vulnerability to LSD1 inhibition. Oncogene. 41(6). 852–864. 26 indexed citations
17.
Ye, Xiaoying, et al.. (2022). Establishment of a prediction model for disease progression within one year in newly diagnosed multiple myeloma patients. Hematology. 27(1). 575–582. 1 indexed citations
18.
Wen, Shijun, Fang Liu, Zijian Zhang, et al.. (2021). CRISPR/Cas9 screening identifies a kinetochore‐microtubule dependent mechanism for Aurora‐A inhibitor resistance in breast cancer. Cancer Communications. 41(2). 121–139. 30 indexed citations
19.
Yuan, Jing, Lin Chen, Ji Zhang, et al.. (2019). SHROOM2 inhibits tumor metastasis through RhoA–ROCK pathway-dependent and -independent mechanisms in nasopharyngeal carcinoma. Cell Death and Disease. 10(2). 58–58. 29 indexed citations
20.
Wang, Zifeng, Masahito Kawabori, & Kiyohiro Houkin. (2019). FTY720 (Fingolimod) Ameliorates Brain Injury through Multiple Mechanisms and is a Strong Candidate for Stroke Treatment. Current Medicinal Chemistry. 27(18). 2979–2993. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026